13F-HR filed by MFN Partners Management, LP
MFN Partners Management, LP filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-14, with 15 holding rows worth $619,965,000.
- Accession
- 0001567619-19-010733
- Filer
- CIK 1732811
- Filed
- 2019-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2019
A holdings report, 15 entries on the cover page, a total value of $619,965,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $619,965,000 with VALUE read as thousands by filing date, 13F file number 028-19231. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALLERGAN PLC | G0177J108 | SHS | 650,101 | $95,181,000 | thousands by filing date | |
| FOX CORP CL A COM | 35137L105 | Stock | 2,369,331 | $86,978,000 | thousands by filing date | |
| PG&E CORP COM | 69331C108 | Stock | 4,000,000 | $71,200,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 4,939,541 | $66,832,000 | thousands by filing date | |
| CHENIERE ENERGY INC COM NEW | 16411R208 | Stock | 750,000 | $51,270,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 1,000,000 | $47,710,000 | thousands by filing date | call |
| XPO INC COM | 983793100 | Stock | 845,500 | $45,437,000 | thousands by filing date | |
| GTT COMMUNICATIONS INC | 362393100 | COM | 1,000,000 | $34,700,000 | thousands by filing date | |
| Goldman Sachs Group,Inc. | 38141G104 | COM | 173,811 | $33,370,000 | thousands by filing date | |
| PIONEER NATURAL RESOURCES CO | 723787107 | COM | 200,000 | $30,456,000 | thousands by filing date | |
| FGL HLDGS | G3402M102 | ORD SHS | 3,000,000 | $23,610,000 | thousands by filing date | |
| TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS | 874060205 | ADR | 785,000 | $15,990,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,500,000 | $8,985,000 | thousands by filing date | |
| NAVIENT CORPORATION COM | 63938C108 | Stock | 650,000 | $7,521,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 46,000 | $725,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-19-010733 | this filing | 2019-05-14 | acceptance time not in the bulk data set |